Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model-Reference-Cited by-同舟云学术

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model

Published:2018-03-28 Issue:3 Volume:13 Page:e0195122
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Genmin,Pine Polly,Leeds Janet M.,DeGuzman Francis,Pratikhya Pratikhya,Lin Joyce,Malinowski John,Hollenbach Stanley J.,Curnutte John T.,Conley Pamela B.^ORCID

Funder

Portola Pharmaceuticals

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Factor Xa inhibitors vs warfarin for preventing stroke and thromboembolism in patients with atrial fibrillation;KM Bruins Slot;JAMA,2014

2. Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin;A Dogliotti;Clin Cardiol,2013

3. Will NOACs become the new standard of care in anticoagulation therapy;E Oktay;Int J Cardiovasc Acad,2015

4. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation—quality and cost implications;NR Desai;Am J Med,2014

5. Edoxaban versus warfarin in patients with atrial fibrillation;RP Giugliano;N Engl J Med,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors;Journal of Thrombosis and Haemostasis;2024-08

2. Andexanet alfa therapy showed No increased rate of thromboembolic events in spontaneous intracranial hemorrhage patients: A multicenter electronic health record study;World Neurosurgery: X;2024-07

3. Reversal and resumption of anticoagulants in patients with anticoagulant-associated intracerebral hemorrhage;European Journal of Medical Research;2024-04-24

4. Grundlagen zur Anwendung von Andexanet;Hämostaseologie;2023-10-09